| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A 16-gene assay to predict recurrence after surgery in localised renal cell carcinoma: development and validation studies
|
Rini, Brian
|
|
2015
|
16 |
6 |
p. 676-685
10 p.
|
artikel
|
| 2 |
Air pollution, climate change, and health
|
Gibson, Josefine
|
|
2015
|
16 |
6 |
p. e269-
1 p.
|
artikel
|
| 3 |
Antibody–drug conjugates in non-Hodgkin lymphoma
|
Lim, Soon Thye
|
|
2015
|
16 |
6 |
p. 607-608
2 p.
|
artikel
|
| 4 |
Anti-PD-L1 for metastatic triple-negative breast cancer
|
Gibson, Josefine
|
|
2015
|
16 |
6 |
p. e264-
1 p.
|
artikel
|
| 5 |
Aprepitant for paediatric chemotherapy-induced nausea and vomiting
|
Batra, Atul
|
|
2015
|
16 |
6 |
p. e259-e260
nvt p.
|
artikel
|
| 6 |
Aprepitant for paediatric chemotherapy-induced nausea and vomiting
|
Slimano, Florian
|
|
2015
|
16 |
6 |
p. e259-
1 p.
|
artikel
|
| 7 |
Aprepitant for paediatric chemotherapy-induced nausea and vomiting – Authors' reply
|
Green, Stuart
|
|
2015
|
16 |
6 |
p. e560-e561
nvt p.
|
artikel
|
| 8 |
ASTRO issues new guidance for radiotherapy in NSCLC
|
Yaqub, Farhat
|
|
2015
|
16 |
6 |
p. e268-
1 p.
|
artikel
|
| 9 |
Bevacizumab: the phoenix of breast oncology?
|
Andre, Fabrice
|
|
2015
|
16 |
6 |
p. 600-601
2 p.
|
artikel
|
| 10 |
CA-125 blood test in early detection of ovarian cancer
|
Burki, Talha Khan
|
|
2015
|
16 |
6 |
p. e269-
1 p.
|
artikel
|
| 11 |
Chemotherapy and radiotherapy in nasopharyngeal carcinoma: an update of the MAC-NPC meta-analysis
|
Blanchard, Pierre
|
|
2015
|
16 |
6 |
p. 645-655
11 p.
|
artikel
|
| 12 |
Children with advanced cancer need symptomatic treatments
|
Bagcchi, Sanjeet
|
|
2015
|
16 |
6 |
p. e266-
1 p.
|
artikel
|
| 13 |
Clinical implications of genomics for cancer risk genetics
|
Thomas, David M
|
|
2015
|
16 |
6 |
p. e303-e308
nvt p.
|
artikel
|
| 14 |
Clinical outcomes in women with breast cancer and a PALB2 mutation: a prospective cohort analysis
|
Cybulski, Cezary
|
|
2015
|
16 |
6 |
p. 638-644
7 p.
|
artikel
|
| 15 |
Controversies in defining cancer survivorship
|
Dirven, Linda
|
|
2015
|
16 |
6 |
p. 610-612
3 p.
|
artikel
|
| 16 |
Correction to Lancet Oncol 2015; 16: 522–30
|
|
|
2015
|
16 |
6 |
p. e262-
1 p.
|
artikel
|
| 17 |
Correction to Lancet Oncol 2015; 16: 499–508
|
|
|
2015
|
16 |
6 |
p. e262-
1 p.
|
artikel
|
| 18 |
Correction to Lancet Oncol 2015; 16: 324
|
|
|
2015
|
16 |
6 |
p. e262-
1 p.
|
artikel
|
| 19 |
Correction to Lancet Oncol 2014; 15: 1324
|
|
|
2015
|
16 |
6 |
p. e262-
1 p.
|
artikel
|
| 20 |
Effect of PALB2 status on breast cancer precision medicine
|
Delaloge, Suzette
|
|
2015
|
16 |
6 |
p. 598-600
3 p.
|
artikel
|
| 21 |
Efficacy of neoadjuvant bevacizumab added to docetaxel followed by fluorouracil, epirubicin, and cyclophosphamide, for women with HER2-negative early breast cancer (ARTemis): an open-label, randomised, phase 3 trial
|
Earl, Helena M
|
|
2015
|
16 |
6 |
p. 656-666
11 p.
|
artikel
|
| 22 |
Generic drug market: growing and merging
|
The Lancet Oncology,
|
|
2015
|
16 |
6 |
p. 595-
1 p.
|
artikel
|
| 23 |
Hepatitis C virus associated with high rates of cancer
|
Burki, Talha Khan
|
|
2015
|
16 |
6 |
p. e266-
1 p.
|
artikel
|
| 24 |
Immunotherapy combination promising for melanomas
|
Brower, Vicki
|
|
2015
|
16 |
6 |
p. e265-
1 p.
|
artikel
|
| 25 |
Negative PET: good prognosis for Hodgkin's lymphoma
|
Bagcchi, Sanjeet
|
|
2015
|
16 |
6 |
p. e265-
1 p.
|
artikel
|
| 26 |
Next-generation (epi)genetic drivers of childhood brain tumours and the outlook for targeted therapies
|
Northcott, Paul A
|
|
2015
|
16 |
6 |
p. e293-e302
nvt p.
|
artikel
|
| 27 |
Panobinostat active against diffuse intrinsic pontine glioma
|
Bagcchi, Sanjeet
|
|
2015
|
16 |
6 |
p. e267-
1 p.
|
artikel
|
| 28 |
Parenthood in adult female survivors treated for Hodgkin's lymphoma during childhood and adolescence: a prospective, longitudinal study
|
Brämswig, Jürgen H
|
|
2015
|
16 |
6 |
p. 667-675
9 p.
|
artikel
|
| 29 |
Parenthood in female survivors of Hodgkin's lymphoma
|
Wallace, W Hamish
|
|
2015
|
16 |
6 |
p. 601-603
3 p.
|
artikel
|
| 30 |
Pattern of change in telomere length: possible predictor of cancer
|
Tanday, Sanjay
|
|
2015
|
16 |
6 |
p. e267-
1 p.
|
artikel
|
| 31 |
Pazopanib and depot octreotide in advanced, well-differentiated neuroendocrine tumours: a multicentre, single-group, phase 2 study
|
Phan, Alexandria T
|
|
2015
|
16 |
6 |
p. 695-703
9 p.
|
artikel
|
| 32 |
Pazopanib: a new drug for pancreatic neuroendocrine tumours
|
Kwekkeboom, Dik J
|
|
2015
|
16 |
6 |
p. 606-607
2 p.
|
artikel
|
| 33 |
Pembrolizumab for patients with advanced melanoma
|
Burki, Talha Khan
|
|
2015
|
16 |
6 |
p. e264-
1 p.
|
artikel
|
| 34 |
Positive death: the third wave
|
Harrison, Natalie
|
|
2015
|
16 |
6 |
p. 616-
1 p.
|
artikel
|
| 35 |
Potential new treatments for EGFR-inhibitor-resistant NSCLC
|
Yaqub, Farhat
|
|
2015
|
16 |
6 |
p. e268-
1 p.
|
artikel
|
| 36 |
Prognostication in localised renal cell carcinoma
|
Kroeger, Nils
|
|
2015
|
16 |
6 |
p. 603-604
2 p.
|
artikel
|
| 37 |
Regorafenib plus best supportive care versus placebo plus best supportive care in Asian patients with previously treated metastatic colorectal cancer (CONCUR): a randomised, double-blind, placebo-controlled, phase 3 trial
|
Li, Jin
|
|
2015
|
16 |
6 |
p. 619-629
11 p.
|
artikel
|
| 38 |
Repeal of SGR: US payment reform for Medicare reimbursement
|
Nierengarten, Mary Beth
|
|
2015
|
16 |
6 |
p. 613-
1 p.
|
artikel
|
| 39 |
Reporting of results in DART01/05 GICOR
|
Pisansky, Thomas M
|
|
2015
|
16 |
6 |
p. e258-
1 p.
|
artikel
|
| 40 |
Reporting of results in DART01/05 GICOR – Author's reply
|
Zapatero, Almudena
|
|
2015
|
16 |
6 |
p. e258-e259
nvt p.
|
artikel
|
| 41 |
Response assessment criteria for brain metastases: proposal from the RANO group
|
Lin, Nancy U
|
|
2015
|
16 |
6 |
p. e270-e278
nvt p.
|
artikel
|
| 42 |
SABR in early operable lung cancer: time for evidence
|
Treasure, Tom
|
|
2015
|
16 |
6 |
p. 597-598
2 p.
|
artikel
|
| 43 |
Safety and activity of the anti-CD79B antibody–drug conjugate polatuzumab vedotin in relapsed or refractory B-cell non-Hodgkin lymphoma and chronic lymphocytic leukaemia: a phase 1 study
|
Palanca-Wessels, Maria Corinna A
|
|
2015
|
16 |
6 |
p. 704-715
12 p.
|
artikel
|
| 44 |
Second-line dovitinib in metastatic endometrial cancer
|
Block, Matthew S
|
|
2015
|
16 |
6 |
p. 604-606
3 p.
|
artikel
|
| 45 |
Second-line dovitinib (TKI258) in patients with FGFR2-mutated or FGFR2-non-mutated advanced or metastatic endometrial cancer: a non-randomised, open-label, two-group, two-stage, phase 2 study
|
Konecny, Gottfried E
|
|
2015
|
16 |
6 |
p. 686-694
9 p.
|
artikel
|
| 46 |
Sequencing of agents in castration-resistant prostate cancer
|
Lorente, David
|
|
2015
|
16 |
6 |
p. e279-e292
nvt p.
|
artikel
|
| 47 |
So It Goes
|
Coburn, Cassandra
|
|
2015
|
16 |
6 |
p. 618-
1 p.
|
artikel
|
| 48 |
Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials
|
Chang, Joe Y
|
|
2015
|
16 |
6 |
p. 630-637
8 p.
|
artikel
|
| 49 |
Systemic therapy for advanced basal cell carcinoma
|
Maybury, Catriona M
|
|
2015
|
16 |
6 |
p. 608-610
3 p.
|
artikel
|
| 50 |
Thank You For Playing
|
van Dorn, Aaron
|
|
2015
|
16 |
6 |
p. 615-
1 p.
|
artikel
|
| 51 |
The genesis of the Saving Faces art project
|
Sansom, Clare
|
|
2015
|
16 |
6 |
p. 617-618
2 p.
|
artikel
|
| 52 |
The role of regorafenib in metastatic colorectal cancer
|
Riechelmann, Rachel
|
|
2015
|
16 |
6 |
p. 596-597
2 p.
|
artikel
|
| 53 |
Treatment with two different doses of sonidegib in patients with locally advanced or metastatic basal cell carcinoma (BOLT): a multicentre, randomised, double-blind phase 2 trial
|
Migden, Michael R
|
|
2015
|
16 |
6 |
p. 716-728
13 p.
|
artikel
|
| 54 |
UK Research Councils' new funding criteria for animal studies
|
Xanthos, Dimitris
|
|
2015
|
16 |
6 |
p. e263-
1 p.
|
artikel
|
| 55 |
Use of chemotherapy in patients with metastatic lung cancer
|
Bagcchi, Sanjeet
|
|
2015
|
16 |
6 |
p. e263-
1 p.
|
artikel
|
| 56 |
US National Cancer Institute investigates PSA coding errors
|
Furlow, Bryant
|
|
2015
|
16 |
6 |
p. 614-
1 p.
|
artikel
|
| 57 |
Vismodegib in patients with advanced basal cell carcinoma (STEVIE): a pre-planned interim analysis of an international, open-label trial
|
Basset-Seguin, Nicole
|
|
2015
|
16 |
6 |
p. 729-736
8 p.
|
artikel
|
Tijdschrift beschrijving